Nerve Conduction Studies and Electromyography
J9 · Effective Oct 1, 2015
17 active Medicare policies list R33.9, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
JJ · Effective Nov 5, 2023
JM · Effective Nov 5, 2023
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
5 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of R33.9 |
|---|---|---|
| Prostate Specific Antigen Testing | Apr 15, 2026 | Covered |
| Sacral Nerve Stimulation for Urinary Retention, Urinary Incontinence, and Fecal Incontinence | Oct 1, 2026 | Covered |
| Tibial Nerve Stimulation | Apr 15, 2026 | Covered |
| Policy | Effective | Status of R33.9 |
|---|---|---|
| Botulinum Toxin | Jan 1, 2024 | Covered |
JL · Effective Oct 1, 2025
J9 · Effective Oct 1, 2025
National · Effective Mar 26, 2026
National · Effective Jun 17, 2025
National · Effective Apr 6, 2026
National · Effective Mar 5, 2026
National · Effective Oct 2, 2025
J6 · Effective Apr 1, 2026
| Policy | Effective | Status of R33.9 |
|---|---|---|
| Urodynamic Testing (CP.MP.98) | Not recorded | Covered |